Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 47

1.

Oral Candidiasis: A Disease of Opportunity.

Vila T, Sultan AS, Montelongo-Jauregui D, Jabra-Rizk MA.

J Fungi (Basel). 2020 Jan 16;6(1). pii: E15. doi: 10.3390/jof6010015. Review.

2.

The power of saliva: Antimicrobial and beyond.

Vila T, Rizk AM, Sultan AS, Jabra-Rizk MA.

PLoS Pathog. 2019 Nov 14;15(11):e1008058. doi: 10.1371/journal.ppat.1008058. eCollection 2019 Nov. No abstract available.

3.

Digital Design of a Universal Rat Intraoral Device for Therapeutic Evaluation of a Topical Formulation against Candida-Associated Denture Stomatitis.

Sultan AS, Rizk AM, Vila T, Ji Y, Masri R, Jabra-Rizk MA.

Infect Immun. 2019 Nov 18;87(12). pii: e00617-19. doi: 10.1128/IAI.00617-19. Print 2019 Dec.

PMID:
31527130
4.

Evaluation of the Antifungal and Wound-Healing Properties of a Novel Peptide-Based Bioadhesive Hydrogel Formulation.

Sultan AS, Vila T, Hefni E, Karlsson AJ, Jabra-Rizk MA.

Antimicrob Agents Chemother. 2019 Sep 23;63(10). pii: e00888-19. doi: 10.1128/AAC.00888-19. Print 2019 Oct.

5.

Candida albicans quorum-sensing molecule farnesol modulates staphyloxanthin production and activates the thiol-based oxidative-stress response in Staphylococcus aureus.

Vila T, Kong EF, Ibrahim A, Piepenbrink K, Shetty AC, McCracken C, Bruno V, Jabra-Rizk MA.

Virulence. 2019 Dec;10(1):625-642. doi: 10.1080/21505594.2019.1635418.

6.

Candidalysin Crucially Contributes to Nlrp3 Inflammasome Activation by Candida albicans Hyphae.

Rogiers O, Frising UC, Kucharíková S, Jabra-Rizk MA, van Loo G, Van Dijck P, Wullaert A.

mBio. 2019 Jan 8;10(1). pii: e02221-18. doi: 10.1128/mBio.02221-18.

7.

Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms.

Van Dijck P, Sjollema J, Cammue BP, Lagrou K, Berman J, d'Enfert C, Andes DR, Arendrup MC, Brakhage AA, Calderone R, Cantón E, Coenye T, Cos P, Cowen LE, Edgerton M, Espinel-Ingroff A, Filler SG, Ghannoum M, Gow NAR, Haas H, Jabra-Rizk MA, Johnson EM, Lockhart SR, Lopez-Ribot JL, Maertens J, Munro CA, Nett JE, Nobile CJ, Pfaller MA, Ramage G, Sanglard D, Sanguinetti M, Spriet I, Verweij PE, Warris A, Wauters J, Yeaman MR, Zaat SAJ, Thevissen K.

Microb Cell. 2018 Jun 14;5(7):300-326. doi: 10.15698/mic2018.07.638. Review.

8.

Topical therapy for refractory rhinosinusitis caused by methicillin-resistant Staphylococcus aureus: First report in a prospective series.

Shikani AH, Khoueir N, Jabra-Rizk MA, Shikani HJ, Basaraba RJ, Leid JG.

Auris Nasus Larynx. 2018 Oct;45(5):994-999. doi: 10.1016/j.anl.2018.01.009. Epub 2018 Feb 6.

PMID:
29426723
9.

The oral microbiome: A Lesson in coexistence.

Sultan AS, Kong EF, Rizk AM, Jabra-Rizk MA.

PLoS Pathog. 2018 Jan 25;14(1):e1006719. doi: 10.1371/journal.ppat.1006719. eCollection 2018 Jan. Review. No abstract available.

10.

Engineering improved variants of the antifungal peptide histatin 5 with reduced susceptibility to Candida albicans secreted aspartic proteases and enhanced antimicrobial potency.

Ikonomova SP, Moghaddam-Taaheri P, Jabra-Rizk MA, Wang Y, Karlsson AJ.

FEBS J. 2018 Jan;285(1):146-159. doi: 10.1111/febs.14327. Epub 2017 Nov 29.

11.

Modulation of Staphylococcus aureus Response to Antimicrobials by the Candida albicans Quorum Sensing Molecule Farnesol.

Kong EF, Tsui C, Kucharíková S, Van Dijck P, Jabra-Rizk MA.

Antimicrob Agents Chemother. 2017 Nov 22;61(12). pii: e01573-17. doi: 10.1128/AAC.01573-17. Print 2017 Dec.

12.

Commensal Protection of Staphylococcus aureus against Antimicrobials by Candida albicans Biofilm Matrix.

Kong EF, Tsui C, Kucharíková S, Andes D, Van Dijck P, Jabra-Rizk MA.

mBio. 2016 Oct 11;7(5). pii: e01365-16. doi: 10.1128/mBio.01365-16.

13.

Community-Associated Methicillin-Resistant Staphylococcus aureus: An Enemy amidst Us.

Kong EF, Johnson JK, Jabra-Rizk MA.

PLoS Pathog. 2016 Oct 6;12(10):e1005837. doi: 10.1371/journal.ppat.1005837. eCollection 2016 Oct. Review. No abstract available.

14.

Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework.

Jabra-Rizk MA, Kong EF, Tsui C, Nguyen MH, Clancy CJ, Fidel PL Jr, Noverr M.

Infect Immun. 2016 Sep 19;84(10):2724-39. doi: 10.1128/IAI.00469-16. Print 2016 Oct. Review.

15.

Candida albicans in oral biofilms could prevent caries.

Willems HM, Kos K, Jabra-Rizk MA, Krom BP.

Pathog Dis. 2016 Jul;74(5). pii: ftw039. doi: 10.1093/femspd/ftw039. Epub 2016 Apr 28.

PMID:
27129365
16.

Pathogenesis of Candida albicans biofilm.

Tsui C, Kong EF, Jabra-Rizk MA.

Pathog Dis. 2016 Jun;74(4):ftw018. Review.

17.

Development and In Vivo Evaluation of a Novel Histatin-5 Bioadhesive Hydrogel Formulation against Oral Candidiasis.

Kong EF, Tsui C, Boyce H, Ibrahim A, Hoag SW, Karlsson AJ, Meiller TF, Jabra-Rizk MA.

Antimicrob Agents Chemother. 2015 Nov 23;60(2):881-9. doi: 10.1128/AAC.02624-15. Print 2016 Feb.

18.

Adherence of Streptococcus mutans on lithium disilicate porcelain specimens.

Vo DT, Arola D, Romberg E, Driscoll CF, Jabra-Rizk MA, Masri R.

J Prosthet Dent. 2015 Nov;114(5):696-701. doi: 10.1016/j.prosdent.2015.06.017. Epub 2015 Sep 16.

PMID:
26384535
19.

Periodontal Diseases: Bug Induced, Host Promoted.

Khan SA, Kong EF, Meiller TF, Jabra-Rizk MA.

PLoS Pathog. 2015 Jul 30;11(7):e1004952. doi: 10.1371/journal.ppat.1004952. eCollection 2015 Jul. Review. No abstract available.

20.

The great escape: pathogen versus host.

Kong E, Jabra-Rizk MA.

PLoS Pathog. 2015 Mar 12;11(3):e1004661. doi: 10.1371/journal.ppat.1004661. eCollection 2015 Mar. Review. No abstract available.

Supplemental Content

Loading ...
Support Center